The Chan Zuckerberg Initiative has announced $4.5 million in funding to support 30 pairs of researchers to collaborate and apply novel approaches for gaining greater insight into neurodegenerative disorders.

The milestone in the project paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.

Havn Life is a biotechnology company aimed at improving cognitive performance through the standardized extraction of psychoactive compounds and the development of natural health care products from novel compounds.

Sermo has released new physician insights into the future of tackling Alzheimer's disease.

Corning’s pre-coated Matrigel matrix-3D plates aim to streamline workflows and deliver a more consistent and convenient solution for high throughput environments.

Miltenyi Biotec has announced the UltraMicroscope Blaze, the world’s first fully automated light sheet microscope.

Cellectricon has announced the launch of services offering for exploration of the role of neuroinflammation in chronic pain.

Erisyon, the company that is transforming how we detect, treat, and monitor disease, has today revealed that it is the recipient of a grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF). Erisyon will use the funds to deploy the power of single molecule protein sequencing for the detection and validation of biomarkers that have the potential for early detection of the disease.

VAXIMM has announced that the safety run-in results from the trial are being presented as an oral presentation at the 2020 American Society of Clinical Oncology (ASCO) Virtual Meeting.

BrainVectis adds a Huntington’s disease gene therapy candidate to AskBio’s program.